1. Home
  2. CAR vs NAMS Comparison

CAR vs NAMS Comparison

Compare CAR & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avis Budget Group Inc.

CAR

Avis Budget Group Inc.

HOLD

Current Price

$370.59

Market Cap

3.4B

ML Signal

HOLD

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

HOLD

Current Price

$36.27

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAR
NAMS
Founded
1946
2019
Country
United States
Netherlands
Employees
N/A
100
Industry
Rental/Leasing Companies
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.5B
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
CAR
NAMS
Price
$370.59
$36.27
Analyst Decision
Hold
Strong Buy
Analyst Count
7
8
Target Price
$127.57
$46.75
AVG Volume (30 Days)
2.1M
793.0K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
50.71
N/A
EPS
N/A
N/A
Revenue
$11,652,000,000.00
N/A
Revenue This Year
$2.17
$17.96
Revenue Next Year
$1.78
$540.65
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$66.79
$15.70
52 Week High
$307.97
$42.00

Technical Indicators

Market Signals
Indicator
CAR
NAMS
Relative Strength Index (RSI) 94.42 65.66
Support Level $126.54 $34.05
Resistance Level N/A $37.43
Average True Range (ATR) 32.07 1.71
MACD 21.57 0.62
Stochastic Oscillator 98.13 97.91

Price Performance

Historical Comparison
CAR
NAMS

About CAR Avis Budget Group Inc.

Avis Budget Group Inc is a provider of mobility solutions through its three brands Avis, Budget and Zipcar, as well as several other brands, well recognized in their respective markets. Its brands offer a range of options, from car and truck rental to car sharing. The company operates in two reportable business segments: Americas - (i) vehicle rental operations in North America, South America, Central America and the Caribbean, (ii) car sharing operations in certain of these markets, and (iii) licensees in the areas in which do not operate directly. International - consisting of (i) vehicle rental operations in Europe, the Middle East, Africa, Asia and Australasia, (ii) car sharing operations in certain of these markets, and (iii) licensees in the areas in which do not operate directly.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

Share on Social Networks: